Empleados: 11 (2023.0)Categoría jurídica: 5485Tamaño: PMEFecha de creación: 2011-02-21 (15 años)Estado: ActivaSector de actividad: Commerce de détail de produits pharmaceutiques en magasin spécialiséUbicación: BAILLEUL (59270), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DASSONNEVILLE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DASSONNEVILLE is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BAILLEUL (59270),
this company of category PME
shows in 2024 a net income positive of 154 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2024, SELARL PHARMACIE DASSONNEVILLE generates positive net income of 154 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 75 k€ -> 154 k€.
Resultado neto (2024)
?
Resultado neto
Definición
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Fórmula
Resultado corriente + Resultado excepcional - Impuesto sobre beneficios
154 388 €
Chargement du compte de résultat...
Cuenta de resultados
Poste
Importe
% CA
Evolución
Le compte de résultat détaillé n'est pas disponible pour cette entreprise (liasse simplifiée ou données confidentielles).
Évolution graphique
Mostrar :
Visualización creada con numbers.finance Sources : INPI & BCE - Ajustes : Ministère de l'Économie
Activo
Chargement des données...
Poste
Bruto
Amort.
Neto
%
Evolución
Données de bilan actif non disponibles pour cette entreprise
Pasivo
Chargement des données...
Poste
Ejercicio
%
Evolución
Données de bilan passif non disponibles pour cette entreprise
Ratios de solvencia y endeudamiento
The debt ratio (= Financial debt / Equity x 100) stands at 125%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Ratio de endeudamiento (2024)
?
Ratio de endeudamiento
Definición
Mide la proporción de deuda respecto a los fondos propios.
Fórmula
(Deuda financiera / Fondos propios) x 100
Interpretación
< 50% : Faible 50-100% : Moderado > 100% : Alto
125.383%
Autonomía financiera (2024)
?
Autonomía financiera
Definición
Porcentaje de fondos propios en la financiación total.
Evolución de indicadores de solvencia SELARL PHARMACIE DASSONNEVILLE
Visualización creada con numbers.finance Sources : INPI & BCE - Ajustes : Ministère de l'Économie
Indicador
2017
2018
2019
2020
2021
2022
2023
2024
Ratio de endeudamiento
567.598
495.45
379.859
462.203
276.851
192.917
164.131
125.383
Autonomía financiera
11.671
13.185
15.988
15.563
22.862
28.321
31.688
37.262
Capacidad de reembolso
None
None
None
None
None
None
None
None
Flujo de caja / Ingresos
None%
None%
None%
None%
None%
None%
None%
None%
Positionnement sectoriel
Debt ratio
125.382024
2022
2023
2024
Q1: 16.45
Méd: 58.41
Q3: 154.59
Average-8 pts durante 3 años
In 2024, the debt ratio of SELARL PHARMACIE DASSONNE... (125.38) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
37.26%2024
2022
2023
2024
Q1: 28.92%
Méd: 49.95%
Q3: 69.49%
Average+10 pts durante 3 años
In 2024, the financial autonomy of SELARL PHARMACIE DASSONNE... (37.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Ratios de liquidez
The liquidity ratio (= Current assets / Current liabilities) stands at 242.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Ratio de liquidez (2024)
?
Ratio de liquidez
Definición
Capacidad para pagar las deudas a corto plazo con el activo circulante.
Fórmula
Activo circulante / Pasivo circulante
Interpretación
> 1.5 : Muy bueno 1-1.5 : Correcto < 1 : Risque de liquidité
242.045
Evolución de indicadores de liquidez SELARL PHARMACIE DASSONNEVILLE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicador
2017
2018
2019
2020
2021
2022
2023
2024
Ratio de liquidez
125.598
116.457
95.231
332.082
266.495
211.745
223.679
242.045
Cobertura de intereses
None
None
None
None
None
None
None
None
Positionnement sectoriel
Liquidity ratio
242.042024
2022
2023
2024
Q1: 129.47
Méd: 182.14
Q3: 260.79
Good+15 pts durante 3 años
In 2024, the liquidity ratio of SELARL PHARMACIE DASSONNE... (242.04) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positionnement de SELARL PHARMACIE DASSONNEVILLE dans son secteur
Comparación con el sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Estimación de valoración
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DASSONNEVILLE is estimated at
2 155 370 €
(range 1 500 966€ - 3 224 557€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1500k€2155k€3224k€
2 155 370 €Range: 1 500 966€ - 3 224 557€
NAF 5 année 2024
Valuation method used
Net Income Multiple
154 388 €
×
14.0x
=2 155 371 €
Range: 1 500 966€ - 3 224 558€
Only this financial indicator is available for this company.
Evolución de la valoración
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DASSONNEVILLE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DASSONNEVILLE
What is the revenue of SELARL PHARMACIE DASSONNEVILLE ?
The revenue of SELARL PHARMACIE DASSONNEVILLE is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DASSONNEVILLE profitable?
Yes, SELARL PHARMACIE DASSONNEVILLE generated a net profit of 154 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DASSONNEVILLE ?
The headquarters of SELARL PHARMACIE DASSONNEVILLE is located in BAILLEUL (59270), in the department Nord.
Where to find the tax return of SELARL PHARMACIE DASSONNEVILLE ?
The tax return of SELARL PHARMACIE DASSONNEVILLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DASSONNEVILLE operate?
SELARL PHARMACIE DASSONNEVILLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Gire su teléfono en modo horizontal para ver el gráfico